Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$460.00 USD
-4.92 (-1.06%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $460.01 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (79 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.87 | 1.38 | 9.99 |
Current Quarter Estimate | 4.11 | 3.11 | 61.00 |
Year Ago Quarter Estimate | 4.08 | -4.81 | 54.84 |
Next Quarter Estimate | 4.10 | 3.91 | 63.00 |
Next Year Estimate | 18.03 | 24.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -99.67 | 17.30 | 15.67 |
Next Year | 35,960.00 | 9.90 | 11.34 |
Last 5 Years | 38.20 | 0.90 | 8.10 |
Next 5 Years | 12.50 | 21.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 2,213.91 | -6.90 |
Price/Book (MRQ) | 8.12 | 2.10 |
Price/Cash Flow (MRFY) | 31.72 | 16.43 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -4.74% | -150.51% |
Return on Equity (TTM) | -2.45% | -61.16% |
Debt to Equity (MRQ) | 0.02 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.